Sun Pharma's Q1 margins likely to be hit on elevated input costs: Analysts1 / 2 margins likely to be hit on elevated input costs: Analysts to be hit on elevated input costs: Analysts<img alt="to be hit on elevated input costs: Analysts" class="photo-post-story" src="http://testrevampimg.business-standard.com/_media/bs/img/article/2022-09/16/full/1663320035-0085.jpg" title="to be hit on elevated input costs: Analysts"
 "Sun Pharma's Q1 margins likely to be hit on elevated input costs: Analysts")